Prediction of the mechanism of Dictamni Cortex in treating dermatitis, eczema and psoriasis based on "the same treatment for different diseases"

DENG Jialin; QIAN Yayun; YANG Niuniu

doi:10.7619/jcmp.20231043

Journal of Clinical Medicine in Practice > 2023 > 27(15): 108-114, 119. > DOI: 10.7619/jcmp.20231043

DENG Jialin, QIAN Yayun, YANG Niuniu. Prediction of the mechanism of Dictamni Cortex in treating dermatitis, eczema and psoriasis based on "the same treatment for different diseases"[J]. Journal of Clinical Medicine in Practice, 2023, 27(15): 108-114, 119. DOI: 10.7619/jcmp.20231043

Citation:

PDF (4443 KB)

Prediction of the mechanism of Dictamni Cortex in treating dermatitis, eczema and psoriasis based on "the same treatment for different diseases"

1.
College of Medicine of Yangzhou University, Yangzhou, Jiangsu, 225009
2.
Department of Traditional Chinese Medicine, Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu, 225012

More Information

Received Date: March 30, 2023
Revised Date: May 16, 2023
Available Online: September 03, 2023

Graphical Abstract

Abstract

Abstract

Objective
To analyze the molecular targets and related mechanisms of dermatitis, eczema, and psoriasis by Dictamni Cortex through network pharmacology and molecular docking based on "the same treatment for different diseases".
Methods
The main active ingredients of Dictamni Cortex were searched and screened by using the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP) database, and the targets of active ingredients were predicted by the Swiss Target Prediction(STP) database. The relevant targets for the treatment of dermatitis, eczema, and psoriasis were obtained by TTD, OMIM, DrugBank, GeneCards, and DisGeNET database, and Venny software was used to obtain the same targets for dermatitis, eczema, and psoriasis, as well as targets that interacted with the active ingredients of Dictamni Cortex. Cytoscape was used to draw the network map, and the STRING database was used to construct the protein interaction network map of the same target genes of Dictamni Cortex in the treatment of dermatitis, eczema, and psoriasis. Metascape database was used for Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, and R language was used for visualization. Molecular docking and visualization were performed through Discovery Studio 2019 Client, AutoDock Tools, and PyMOL.
Results
A total of 15 active ingredients from Dictamni Cortex were obtained, and there were 64 intersection targets for the same targets of Dictamni Cortex and dermatitis, eczema, and psoriasis. The core targets of the active ingredients of Dictamni Cortex in the treatment of dermatitis, eczema, and psoriasis were tumor necrosis factor (TNF), toll-like receptor 4(TLR4), vascular endothelial growth factor A(VEGFA), signal transduction and transcription activator 3(STAT3), signal transduction and transcription activator 1(STAT1), etc. The core pathways included advanced glycosylation end-product-receptor (AGE-RAGE), interleukin-17 (IL-17), Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway, etc.
Conclusion
Dictamni Cortex may act on multiple targets such as TNF, TLR4 and VEGFA through multiple pathways including IL-17, JAK-STAT and AGE-RAGE to exert anti-inflammatory and anti-itch effects in dermatitis, eczema and psoriasis.
- Dictamni Cortex,
- dermatitis,
- eczema,
- psoriasis,
- network pharmacology,
- molecular docking,
- intersection target,
- signal pathway

FullText(HTML)

References (31)

References

[1]	ELSNER P, AGNER T. Hand eczema: treatment[J]. J Eur Acad Dermatol Venereol, 2020, 34(Suppl 1): 13-21.
[2]	CHEN Y C, YAN Y H, LIU H Z, et al. Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8⁺ T-cell memory in wild-type and humanized mice[J]. Theranostics, 2020, 10(23): 10466-10482. doi: 10.7150/thno.45211
[3]	陆家睛, 史玉玲. 糖皮质激素在皮肤科的应用[J]. 皮肤科学通报, 2021, 38(4): 304-311. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXW202104004.htm
[4]	TOKUYAMA M, MABUCHI T. New treatment addressing the pathogenesis of psoriasis[J]. Int J Mol Sci, 2020, 21(20): 7488. doi: 10.3390/ijms21207488
[5]	王启斌, 袁昊, 马朝晖, 等. 中药液体制剂在炎性皮肤病中的应用[J]. 江西中医药, 2021, 52(10): 73-76. https://www.cnki.com.cn/Article/CJFDTOTAL-JXZY202110035.htm
[6]	GAO P, WANG L, ZHAO L, et al. Rapid identification, isolation, and evaluation on anti-neuroinflammatory activity of limonoids derivatives from the root bark of Dictamnus dasycarpus[J]. J Pharm Biomed Anal, 2021, 200: 114079. doi: 10.1016/j.jpba.2021.114079
[7]	陈佳骏, 杨妞妞. 白鲜皮及其活性成分抗炎止痒机制研究进展[J]. 江西中医药, 2020, 51(5): 77-80. https://www.cnki.com.cn/Article/CJFDTOTAL-JXZY202005033.htm
[8]	邵海峰, 杨妞妞, 刘延庆. 基于数据挖掘的中医治疗湿疹用药规律分析[J]. 实用临床医药杂志, 2021, 25(24): 83-86, 96. doi: 10.7619/jcmp.20212927
[9]	YANG S C, SUN F, RUAN J Y, et al. Anti-inflammatory constituents from cortex dictamni[J]. Fitoterapia, 2019, 134: 465-473. doi: 10.1016/j.fitote.2019.03.026
[10]	ZHOU Z C, CHEN B, CHEN S M, et al. Applications of network pharmacology in traditional Chinese medicine research[J]. Evid Based Complement Alternat Med, 2020, 2020: 1646905.
[11]	RU J L, LI P, WANG J N, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines[J]. J Cheminform, 2014, 6: 13. doi: 10.1186/1758-2946-6-13
[12]	DONG Y Z, ZHAO Q L, WANG Y G. Network pharmacology-based investigation of potential targets of astragalus membranaceous-Angelica sinensis compound acting on diabetic nephropathy[J]. Sci Rep, 2021, 11(1): 19496. doi: 10.1038/s41598-021-98925-6
[13]	胡伟, 李晨, 王晨光, 等. 基于UPLC-Q-Qrbitrap HRMS和网络药理学探究芪胶升白胶囊治疗白细胞减少症的作用机制[J]. 现代药物与临床, 2023, 9(2): 289-299. https://www.cnki.com.cn/Article/CJFDTOTAL-GWZW202302006.htm
[14]	UNIPROT CONSORTIUM. UniProt: a worldwide hub of protein knowledge[J]. Nucleic Acids Res, 2019, 47(D1): D506-D515. doi: 10.1093/nar/gky1049
[15]	ZHOU Y Y, ZHOU B, PACHE L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets[J]. Nat Commun, 2019, 10(1): 1523. doi: 10.1038/s41467-019-09234-6
[16]	YANG X H, LIU H H, LIU J N, et al. Rational selection of the 3D structure of biomacromolecules for molecular docking studies on the mechanism of endocrine disruptor action[J]. Chem Res Toxicol, 2016, 29(9): 1565-1570. doi: 10.1021/acs.chemrestox.6b00245
[17]	ZHANG B Y, ZHAO J, WANG Z, et al. Identification of multi-target anti-AD chemical constituents from traditional Chinese medicine formulae by integrating virtual screening and in vitro validation[J]. Front Pharmacol, 2021, 12: 709607. doi: 10.3389/fphar.2021.709607
[18]	LI B J, RUI J Q, DING X J, et al. Exploring the multicomponent synergy mechanism of Banxia Xiexin Decoction on irritable bowel syndrome by a systems pharmacology strategy[J]. J Ethnopharmacol, 2019, 233: 158-168. doi: 10.1016/j.jep.2018.12.033
[19]	KRIEF S, MARTIN M T, GRELLIER P, et al. Novel antimalarial compounds isolated in a survey of self-medicative behavior of wild chimpanzees in Uganda[J]. Antimicrob Agents Chemother, 2004, 48(8): 3196-3199. doi: 10.1128/AAC.48.8.3196-3199.2004
[20]	MANNINO G, IOVINO P, LAURIA A, et al. Bioactive triterpenes of Protium heptaphyllum gum resin extract display cholesterol-lowering potential[J]. Int J Mol Sci, 2021, 22(5): 2664. doi: 10.3390/ijms22052664
[21]	YOON J Y, WANG J Y, ROEHRL M H A. An investigation into the prognostic significance of high proteasome PSB₇ protein expression in colorectal cancer[J]. Front Med, 2020, 7: 401. doi: 10.3389/fmed.2020.00401
[22]	PŁÓCIENNIKOWSKA A, HROMADA-JUDYCKA A, BORZECKA K, et al. Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling[J]. Cell Mol Life Sci, 2015, 72(3): 557-581. doi: 10.1007/s00018-014-1762-5
[23]	邓斌, 罗庆, 宋关斌. COX2通过HIF-1α/VEGFA/PDGFB信号通路增强炎性肌腱细胞的促血管新生能力[J]. 医用生物力学, 2021, 36(S01): 188-188. https://www.cnki.com.cn/Article/CJFDTOTAL-YISX2021S1359.htm
[24]	BENHADOU F, GLITZNER E, BRISEBARRE A, et al. Epidermal autonomous VEGFA/Flt1/Nrp1 functions mediate psoriasis-like disease[J]. Sci Adv, 2020, 6(2): eaax5849. doi: 10.1126/sciadv.aax5849
[25]	BUTTURINI E, CARCERERI DE PRATI A, MARIOTTO S. Redox regulation of STAT1 and STAT3 signaling[J]. Int J Mol Sci, 2020, 21(19): 7034. doi: 10.3390/ijms21197034
[26]	JU X, YANG X, YAN T, et al. EGFR inhibitor, AG1478, inhibits inflammatory infiltration and angiogenesis in mice with diabetic retinopathy[J]. Clin Exp Pharmacol Physiol, 2019, 46(1): 75-85. doi: 10.1111/1440-1681.13029
[27]	KIM E N, KAYGUSUZ O, LEE H S, et al. Simultaneous quantitative analysis of ginsenosides isolated from the fruit of Panax ginseng C. A. Meyer and regulation of HO-1 expression through EGFR signaling has anti-inflammatory and osteogenic induction effects in HPDL cells[J]. Molecules, 2021, 26(7): 2092. doi: 10.3390/molecules26072092
[28]	AL BARASHDI M A, ALI A, MCMULLIN M F, et al. Protein tyrosine phosphatase receptor type C (PTPRC or CD45)[J]. J Clin Pathol, 2021, 74(9): 548-552. doi: 10.1136/jclinpath-2020-206927
[29]	SU W X, ZHAO Y, WEI Y Q, et al. Exploring the pathogenesis of psoriasis complicated with atherosclerosis via microarray data analysis[J]. Front Immunol, 2021, 12: 667690. doi: 10.3389/fimmu.2021.667690
[30]	LIU C, TATE T, BATOURINA E, et al. Pparg promotes differentiation and regulates mitochondrial gene expression in bladder epithelial cells[J]. Nat Commun, 2019, 10(1): 4589.
[31]	RUMZHUM N N, AMMIT A J. Cyclooxygenase 2: its regulation, role and impact in airway inflammation[J]. Clin Exp Allergy, 2016, 46(3): 397-410.

[1]	LU Junwei, ZHU Jingzhe, CHEN Hongru, XIE Jumin. Molecular mechanism of luteolin in treatment of cervical cancer based on network pharmacology and molecular docking technology[J]. Journal of Clinical Medicine in Practice, 2024, 28(16): 26-33. DOI: 10.7619/jcmp.20241525
[2]	WANG Zhenglin, CHANG Weicai, LIU Xinyu, CHEN Jiawei, LIU Zixiang, ZHOU Shaobo. Role of tumor necrosis factor-α in promoting gallbladder cancer cell proliferation through Wnt/β-catenin signaling pathway[J]. Journal of Clinical Medicine in Practice, 2023, 27(19): 40-45. DOI: 10.7619/jcmp.20230255
[3]	YI Jinling, Tubikezi·YIBILI, Gulihumaer·AINIWAER, LA Xiaolin. Effect of TAM family receptor tyrosine kinases on signaling pathway of mammalian target of rapamycin in patients with endometriosis[J]. Journal of Clinical Medicine in Practice, 2023, 27(2): 7-12, 16. DOI: 10.7619/jcmp.20223087
[4]	YANG Yanni, ZHAO Ziwei, LI Xinhua. Research progress of mitogen activated protein kinase signaling pathway in pathogenesis of psoriasis vulgaris[J]. Journal of Clinical Medicine in Practice, 2022, 26(18): 136-139. DOI: 10.7619/jcmp.20220406
[5]	ZHANG Feng, ZHENG Gang, QI Jing, GAO Yuan. Research progress of inflammatory signaling pathway associated with atherosclerosis[J]. Journal of Clinical Medicine in Practice, 2022, 26(10): 144-148. DOI: 10.7619/jcmp.20214777
[6]	JIN Xuening, LIN Fei, FENG Xinyi, LI Cen, CUI Shu′na. Mechanism of docetaxel in treatment of choriocarcinoma based on network pharmacology[J]. Journal of Clinical Medicine in Practice, 2022, 26(1): 18-21. DOI: 10.7619/jcmp.20213494
[7]	CAO Qin, WANG Dan. Mechanism of ropivacaine inhibiting the proliferation, migration and invasion of gastric cancer cell NCI-N87 through Wnt signaling pathway[J]. Journal of Clinical Medicine in Practice, 2021, 25(20): 56-60, 67. DOI: 10.7619/jcmp.20211771
[8]	LIU Juan, CHEN Canming, XU Yang, ZHANG Wei, ZHANG Lei. Interaction between aromatic hydrocarbon receptor signaling pathway-related gene polymorphism and its mRNA in the development of endometriosis[J]. Journal of Clinical Medicine in Practice, 2019, 23(13): 1-5, 9. DOI: 10.7619/jcmp.201913001
[9]	WANG Hua, WANG Jingcheng, WANG Yongxiang, WANG Daxin, TAO Yuping, FENG Xinmin, XIONG Chuanzhi, GU Jiaxiang, HE Jinshan. Role of NEP1-40 in regulation of Wnt signaling pathway and regeneration of neural cells in neonatal rats with hypoxic ischemic encephalopathy[J]. Journal of Clinical Medicine in Practice, 2017, (5): 1-4. DOI: 10.7619/jcmp.201705001
[10]	LI Juan. Participation mechanism of TGFβ/Smad signaling pathway in the pathogenesis of cognitive dysfunction in cerebral infarction patients[J]. Journal of Clinical Medicine in Practice, 2015, (17): 21-23,27. DOI: 10.7619/jcmp.201517007

Cited By

Cited by

Periodical cited type(1)

林柳雁，王丽，萧绮莉，蒋小红，陈惠冰. 成人炎症性肠病患者经口营养管理的证据总结. 护理实践与研究. 2025(02): 244-251 .

Other cited types(1)

Get Citation

PDF

XML

Article views (149) PDF downloads (14) Cited by(2)

Turn off MathJax

Article Contents

Abstract

References

Prediction of the mechanism of Dictamni Cortex in treating dermatitis, eczema and psoriasis based on "the same treatment for different diseases"